Skip to main content

Table 2 Mixed Model analyses, effect differences for outcome domains

From: E-IMR: e-health added to face-to-face delivery of Illness Management & Recovery programme for people with severe mental illness, an exploratory clustered randomized controlled trial

  Model 1 Model 2 Model 3 Model 4
Main group effects Confounder analyses of covariate gender Interaction analyses of covariate non-completer Sub-group analyses within intervention group
Outcome domains Parameter T1*Group T2*Group T0*Male T1*Male T2*Male T1*Group T2*Group T0* completer T1*Group T1*Group* completer T2*Group T2*Group* completer T1*e-IMR-users T2*e-IMR-users
Illness management: IMRS effect 2.55 3.06 4.89 −2.31 −3.26 2.26 2.42 1.57 1.12 .62 2.38 .74 1.89 1.71
p .13 .07 .00** .19 .08 .19 .17 .38 .70 .86 .41 .84 .32 .44
Self-management: PAM-13 effect 7.95 3.90 4.40 .75 1.76 8.71 5.04 1.52 17.72 −15.13 6.80 −4.81 −.73 3.03
p .01* .22 .19 .82 .62 .01* .14 .67 .00* .03* .21 .48 .81 .40
Recovery: MHRM effect 7.23 5.06 12.69 −7.02 −3.55 5.35 4.42 6.89 13.36 −10.90 8.09 −3.85 3.27 .84
p .02* .11 .00** .03* .28 .10 .19 .13 .01* .10 .14 .57 .32 .82
Symptoms: BSI effect −.07 −.13 −.60 .28 .31 −.02 −.07 −.13 .08 −.12 .06 −.24 −.18 −.22
p .58 .30 .00** .03* .02* .90 .62 .47 .72 .66 .77 .39 .19 .17
Quality of Life: MANSA effect .15 .11 .37 −.22 −.36 .10 .00 .10 .49 −.58 −.04 .24 .10 .12
p .35 .52 .07 .18 .04* .57 .99 .65 .08 .09 .90 .50 .57 .55
General Health Status: Rand-PF effect 6.61 5.21 19.87 3.57 −6.59 8.73 3.63 −3.92 13.2 −13.01 6.1 −3.17 −.48 6.78
p .16 .27 .00** .45 .18 .07 .46 .58 .11 .20 .46 .76 .93 .26
Rand-SF effect −.02 .93 15.91 −1.24 −14.26 −1.67 −2.24 1355 2.04 −7.55 −3.39 5.04 .35 9.07
p 1.00 .88 .02* .13 .04* .80 .74 .04* .85 .58 .76 .71 .96 .24
Rand-RLPP effect 9.47 7.88 29.85 −3.43 −13.61 9.98 4.68 −11.85 29.73 −32.31 11.28 −6.33 −6.56 4.99
p .39 .48 .01* .76 .26 .39 .69 .36 .12 .17 .55 .79 .59 .73
Rand-RLEP effect −25.58 9.47 29.18 −9.99 −17.38 − 21.33 11.43 8.18 −28.77 5.24 −21.27 44.85 −18.90 23.40
p .03* .43 .01** .46 .22 .09 .37 .47 .16 .84 .31 .08* .15 .13
Rand-MH effect −2.40 −1.09 15.11 −6.73 −5.80 −3.85 −2.17 8.07 −.50 −5.33 −4.94 5.65 2.24 −.83
p .57 .80 .00** .13 .21 .39 .64 .13 .95 .56 .50 .54 .61 .87
Rand-V effect −.26 .91 15.11 −3.18 −7.04 .55 .35 8.76 14.76 −22.9 8.6 −8.36 −7.62 −9.42
p .96 .85 .00** .53 .19 .92 .95 .11 .07 .03* .30 .42 .11 .09
Rand-P effect 1.63 −3.46 21.37 2.74 −1.11 6.01 −3.74 −10.34 −4.51 2.84 −6.01 .68 2.14 −1.73
p .82 .63 .00** .72 .21 .42 .62 .19 .72 .85 .63 .97 .80 .28
Rand-GHP effect 7.84 1.10 15.21 −2.91 −13.97 7.13 5.31 1.65 9.28 −3.13 9.44 3.43 −3.01 5.26
p .07 .02* .00** .50 .00** .10 .23 .76 .22 .73 .21 .71 .53 .35
  1. BSI Brief Symptom Inventory, e-IMR e-health application to Illness Management & Recovery programme, IMRS Illness Management & Recovery Scales, MANSA Manchester Short Assessment of Quality of Life, MHRM Mental Health Recovery Measure, p p-value, PAM Patient Activation Measure, Rand-GHP Rand General Health Perception, Rand-MH Rand Mental Health, Rand-P Rand Pain, Rand-PF Rand Physical Functioning, Rand-SF Rand Social Functioning, Rand-RLEP Rand Role Limitation due to Emotional Problems, Rand-RLPP Rand Role Limitation due to Physical Problems, Rand-V Rand Vitality; *p-value < .05; **p-value < .01